These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37832041)
1. Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review. Feng R; Lin Q; Wei D; Li Y; Zhang R; Jiang K; Li Y; Xie L; Xia J; Zheng P; Ji X; Wang W; Qu X; Gao Q; Pan Y; Liu J Medicine (Baltimore); 2023 Oct; 102(41):e35405. PubMed ID: 37832041 [TBL] [Abstract][Full Text] [Related]
2. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis. Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841 [TBL] [Abstract][Full Text] [Related]
3. [Shensong Yangxin Capsules in the adjuvant treatment of stable angina pectoris:a Meta-analysis and trial sequential analysis]. Xi YT; Yuan LY; Zeng YY; Yan ML; Liang XR; Feng AT; Wu W Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3816-3824. PubMed ID: 31602958 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis. Li L; Feng P; Zhou W; Luo B; Deng L; Gan D; Wu X; Zhu F; Zhou X Front Cardiovasc Med; 2024; 11():1229299. PubMed ID: 38414926 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Tongxinluo Capsule as Adjunctive Treatment for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Li P; Xin Q; Hui J; Yuan R; Wang Y; Miao Y; Lee SM; Leng SX; Cong W; Front Pharmacol; 2021; 12():742978. PubMed ID: 34707500 [TBL] [Abstract][Full Text] [Related]
6. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. Lv J; Liu S; Guo S; Gao J; Song Q; Cui X J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hui J; Yuan R; Li P; Xin Q; Miao Y; Shen X; Xu F; Cong W J Clin Med; 2022 May; 11(11):. PubMed ID: 35683377 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris: Protocol for a systematic review. Chen M; Li M; Ou L; Kuang R; Chen Y; Li T; Men L; Zhang J; Zhang Z Medicine (Baltimore); 2018 Aug; 97(34):e11680. PubMed ID: 30142757 [TBL] [Abstract][Full Text] [Related]
10. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials. Zhang Y; Xie Y; Liao X; Jia Q; Chai Y Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of the effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris. Chen M; Men L; Wu H; Zhong G; Ou L; Li T; Guo Y; Lin H; Zhang J; Wang D; Zhang Z Medicine (Baltimore); 2019 Dec; 98(51):e18375. PubMed ID: 31860998 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Meta-Analysis on the Efficacy of Puerarin Injection as Adjunctive Therapy for Unstable Angina Pectoris. Shao H; Huang Y; Xu D; Huang S; Tong R Front Cardiovasc Med; 2022; 9():763567. PubMed ID: 35282378 [TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis and GRADE evaluation of Guanxinning Tablets in treatment of angina pectoris of coronary heart disease]. Li XY; Sun DX; Xu YN; Gao XH; Fan KF Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):247-255. PubMed ID: 36725277 [TBL] [Abstract][Full Text] [Related]
14. [Network Meta-analysis of Chinese medicine injection combined with conventional western medicine in treatment of stable angina pectoris]. Wang W; Cao L; Ren P; Zhu BB; Liu K Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1652-1663. PubMed ID: 37005853 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of Xueshuantong (lyophilized) for injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis. Xi J; Wei R; Cui X; Liu Y; Xie Y Front Pharmacol; 2023; 14():1074400. PubMed ID: 37089918 [No Abstract] [Full Text] [Related]
16. Systematic Review of the Efficacy and Safety of Shuxuening Injection in the Treatment of Unstable Angina. Fan G; Liu M; Liu J; Chen X; Huang Y Evid Based Complement Alternat Med; 2022; 2022():6650763. PubMed ID: 35211180 [TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of Pan L; Zhai X; Duan Z; Xu K; Liu G Front Pharmacol; 2022; 13():956313. PubMed ID: 36160405 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis. Mao W; Lu P; Wan R; Mao K; Lv Y; Hu J; Fu Z; Wang J Front Cardiovasc Med; 2023; 10():1100006. PubMed ID: 37351285 [TBL] [Abstract][Full Text] [Related]
19. Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta-analysis. Shi S; Yu B; Li W; Shan J; Ma T Phytother Res; 2019 Nov; 33(11):2862-2869. PubMed ID: 31423665 [TBL] [Abstract][Full Text] [Related]
20. [Adjunctive therapy of xuezhikang capsule for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials]. Wang Y; Chen ZH; Liu GH; Zhang F; Zhang Z; Guan XF; Luo ZB; Yang GL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1182-91. PubMed ID: 25509259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]